Neogenomics INC (NEO) SEC Filings — 2024
16 SEC filings for Neogenomics INC (NEO) in 2024.
Filings
- Neogenomics INC SC 13G Filing — SC 13G · Nov 14, 2024
- Neogenomics INC SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- NeoGenomics Files 8-K: Operations, Board & Officer Changes — 8-K · Nov 5, 2024
- NeoGenomics Q2 2024: $235.7M Revenue, $36.7M Net Loss — 10-Q · Jul 30, 2024
- NeoGenomics Inc. Files 8-K on Financials — 8-K · Jul 29, 2024
- NeoGenomics Holds Annual Stockholder Meeting — 8-K · May 24, 2024
- NeoGenomics, Inc. Reports First Quarter 2024 Financial Results — 10-Q · Apr 30, 2024
- NeoGenomics Appoints New CEO, Dr. Mark Mallon — 8-K · Apr 18, 2024
- NEOGENOMICS INC Files DEF 14A with Executive Compensation Details — DEF 14A · Apr 8, 2024
- NeoGenomics Amends 8-K Filing on Officer Changes and Compensation — 8-K/A · Feb 26, 2024
- NeoGenomics Grants Performance Share Units to Officers — 8-K · Feb 23, 2024
- Neogenomics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 20, 2024
- Neogenomics INC SC 13G Filing — SC 13G · Feb 14, 2024
- Neogenomics INC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Brown Advisory Amends NEO Stake, Confirms Continued Investment — SC 13G/A · Feb 9, 2024
- BlackRock Amends NeoGenomics Stake to 9.5% as of Dec 31, 2023 — SC 13G/A · Jan 22, 2024